# Codex Review: b6_defer_outcome_contract_20260802

Date: 2026-08-02
Delegated-agent output: none; direct Codex execution.

## Verdict

Pass for the bounded user-authorized defer-state contract; not a medical approval, migration or release acceptance.

## Boundary Check

- No delegated agent was used. The B6 review input, B6/C14 evidence, coverage rebind and the scoped C14 contract/test were the only changed surfaces; no runtime database or protected frontend/medical-writing surface was changed.
- Five outcomes are explicitly `pending_review`; no candidate is approved, no blocker is falsely resolved.

## Codex Verification

- B6 gate: `pending_review`, 5 candidates, 5 outcomes, 0 missing, 5 pending; write/migration false.
- C14 report: 46/46 rows blocked; activation/event/projection false.
- C14 focused regression: **17 passed**; py_compile passed.
- Coverage rebind: current B6 SHA `1f3df053b094c3b6f974e1deec78f17446b03c00e54557b667fcd159ac05557e`, release-audit SHA `2ce0fc4ea8b789c6cec5445bfb79318fa96c20e4cbb0d9558aef301f8e0ae33d`, current coverage SHA `e618f21fb9a9a8cba553778accd0898163a9ab87571040ed0620ba497c78af2e`, decision SHA `08f5a0b4b1a3bd74ae4b39fd776e0da4d529520455c4fb26f78466745409a02d`.
- Hermes workflow guard is only task-record integrity; no Hermes/provider dispatch occurred.

## Delegated-Agent Output Review

- The C14 change distinguishes missing outcomes from explicit pending/defer outcomes and enforces candidate category/count conservation. It does not assert clinical validity or source equivalence.

## Residual Risk

MY009 source-token and append-only aggregate blockers remain; RUX exact identity still requires medical review. Browser/science/UAT, three-project runtime, persistence/restart and commercial release remain unproven.
